Related Experiment Video
Updated: Aug 6, 2026
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Advancing neonatal care: A non-invasive, contactless method for early diagnosis of neurological disorders
Susmita Roy1, Lea Hartmann2, Nadia Feddahi2
1Research Unit of the Buhl-Strohmaier Foundation for Cerebral Palsy and Pediatric Neuroorthopaedics, Department of Orthopaedics and Sports Orthopaedics, TUM School of Medicine and Health, University Hospital Rechts der Isar, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany.
Insights
Diagnosing cerebral palsy in premature infants is challenging. Infrared spectroscopy of exhaled breath identified specific metabolites, offering potential for early diagnosis of neurological conditions in newborns.
Area of Science:
- Biochemistry
- Neonatal Medicine
- Spectroscopy
Background:
- Neonatal encephalopathy from perinatal brain damage is a major cause of cerebral palsy and long-term disability in premature infants.
- Early diagnosis of cerebral palsy is critical for timely intervention, but distinguishing transient delays from permanent deficits is difficult in early childhood.
- Metabolite-based diagnostics present a promising avenue for improving the accuracy and timeliness of diagnoses.
Purpose of the Study:
- To investigate the potential of infrared spectroscopy of exhaled breath for identifying biomarkers of neurological conditions in premature infants.
- To explore specific metabolites in neonatal breath that correlate with physiological and neurological states.
Main Methods:
- Infrared spectroscopy was employed to analyze exhaled breath samples from 71 premature neonates.
- Spectral data was analyzed to identify characteristic metabolite signatures.
Main Results:
- Spectral features indicative of propionic acid esters and methyl butyrate were detected in the exhaled breath of neonates.
- These detected metabolites showed correlations with potential physiological and neurological conditions.
Conclusions:
- Infrared spectroscopy of exhaled breath can detect specific metabolites in premature infants.
- The identified metabolites may serve as potential biomarkers for early diagnosis of neurological conditions, including cerebral palsy, in neonates.
- This non-invasive technique holds promise for improving diagnostic capabilities in neonatal neurology.
Abstract:
Neonatal encephalopathy in premature infants resulting from perinatal brain damage is one of the leading causes of long-term disability, particularly cerebral palsy. Early diagnosis is crucial, as timely intervention can improve outcomes and quality of life. The early identification of cerebral palsy resulting from perinatal brain injury in premature infants remains challenging, as it is difficult to distinguish between transient developmental delays and permanent neurological deficits within the first three years of life. Metabolite-based diagnostics may help bridge this gap. In this study, infrared spectroscopy of exhaled breath from 71 neonates was used to identify metabolites potentially associated with specific physiological and neurological conditions. Spectral features consistent with propionic acid esters and methyl butyrate were detected, both of which show correlations with possible physiological and neurological conditions.
